Pharma Mar S.A. (PHM) — Capital Reinvestment Ratio
Latest as of December 2025:
0.19x
Pharma Mar S.A. (PHM) has a Capital Reinvestment Ratio of 0.19x as of December 2025, meaning it reinvests 0% of its operating cash flow (€33.58 Million) in capital expenditures (€6.26 Million). See how much free cash does Pharma Mar S.A. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.19x
Capex / Operating Cash Flow
Operating Cash Flow
€33.58 Million
EUR
Capital Expenditures
€6.26 Million
EUR
Data as of
Dec 2025
Most recent filing
Pharma Mar S.A. Capital Reinvestment Ratio (2012–2025)
This chart tracks Pharma Mar S.A.'s Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Pharma Mar S.A. (2012–2025)
Year-by-year Capital Reinvestment Ratio for Pharma Mar S.A. from 2012 to 2025. For live market cap and broader valuation context, see PHM stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | €53.13 Million | €9.38 Million | ▼ -93.1% |
| 2024 | 2.57x | €6.03 Million | €15.51 Million | ▲ +1014.1% |
| 2022 | 0.23x | €38.32 Million | €8.85 Million | ▼ -24.0% |
| 2021 | 0.30x | €25.68 Million | €7.80 Million | ▲ +2723.7% |
| 2020 | 0.01x | €278.94 Million | €3.00 Million | ▼ -98.7% |
| 2015 | 0.83x | €11.10 Million | €9.22 Million | ▲ +80.4% |
| 2014 | 0.46x | €22.11 Million | €10.18 Million | ▲ +259.2% |
| 2013 | 0.13x | €16.34 Million | €2.10 Million | ▼ -60.1% |
| 2012 | 0.32x | €6.32 Million | €2.03 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow